200 related articles for article (PubMed ID: 22146078)
1. Docking, CoMFA and CoMSIA studies of a series of sulfonamides derivatives as carbonic anhydrase I inhibitors.
Ghasemi JB; Meftahi N
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):320-7. PubMed ID: 22146078
[TBL] [Abstract][Full Text] [Related]
2. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
Sethi KK; Verma SM
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
Sethi KK; Verma SM; Prasanthi N; Sahoo SK; Parhi RN; Suresh P
Bioorg Med Chem Lett; 2010 May; 20(10):3089-93. PubMed ID: 20443227
[TBL] [Abstract][Full Text] [Related]
4. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
Huang H; Pan X; Tan N; Zeng G; Ji C
Eur J Med Chem; 2007 Mar; 42(3):365-72. PubMed ID: 17118494
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein.
Entezari Heravi Y; Sereshti H; Saboury AA; Ghasemi J; Amirmostofian M; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):688-700. PubMed ID: 28317396
[TBL] [Abstract][Full Text] [Related]
6. Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII.
Supuran CT; Maresca A; Gregáň F; Remko M
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):289-93. PubMed ID: 22299577
[TBL] [Abstract][Full Text] [Related]
7. Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II.
Alp C; Maresca A; Alp NA; Gültekin MS; Ekinci D; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):294-8. PubMed ID: 22380772
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of aminocyanopyrazoles via a multi-component reaction and anti-carbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms.
Allouche F; Chabchoub F; Carta F; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):343-9. PubMed ID: 23013533
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes.
Ekinci D; Fidan İ; Durdagi S; Kaban Ş; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):370-4. PubMed ID: 23173744
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of metal complexes of heterocyclic sulfonamide as carbonic anhydrase inhibitors.
Büyükkidan N; Bülbül M; Kasimoğullari R; Büyükkidan B
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):311-5. PubMed ID: 22957724
[TBL] [Abstract][Full Text] [Related]
11. Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors.
Gitto R; Agnello S; Ferro S; Vullo D; Supuran CT; Chimirri A
ChemMedChem; 2010 Jun; 5(6):823-6. PubMed ID: 20349499
[No Abstract] [Full Text] [Related]
12. More effective dithiocarbamate derivatives inhibiting carbonic anhydrases, generated by QSAR and computational design.
Avram S; Milac AL; Carta F; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):350-9. PubMed ID: 23116520
[TBL] [Abstract][Full Text] [Related]
13. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
[TBL] [Abstract][Full Text] [Related]
14. Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes.
Koz Ö; Ekinci D; Perrone A; Piacente S; Alankuş-Çalişkan Ö; Bedir E; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):412-7. PubMed ID: 22299585
[TBL] [Abstract][Full Text] [Related]
15. 2-Amino-3-cyanopyridine derivatives as carbonic anhydrase inhibitors.
Ayvaz S; Çankaya M; Atasever A; Altuntas A
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):305-10. PubMed ID: 22141460
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors.
Weber A; Böhm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G
J Chem Inf Model; 2006; 46(6):2737-60. PubMed ID: 17125213
[TBL] [Abstract][Full Text] [Related]
17. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
Tarko L; Supuran CT
Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules.
Singh S; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):449-55. PubMed ID: 23808803
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of novel pyrazole carboxamide derivatives on human carbonic anhydrase enzyme.
Şen E; Alim Z; Duran H; İşgör MM; Beydemir Ş; Kasimoğullari R; Ok S
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):328-36. PubMed ID: 22299586
[TBL] [Abstract][Full Text] [Related]
20. QSAR study on benzenesulphonamide carbonic anhydrase inhibitors: topological approach using Balaban index.
Thakur A; Thakur M; Khadikar PV; Supuran CT; Sudele P
Bioorg Med Chem; 2004 Feb; 12(4):789-93. PubMed ID: 14759739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
